Skip navigation

Overcome Patient Affordability Barriers in an Evolving Managed Care Landscape

April 11-12, 2018
  • San Francisco, CA

Facilitating patient affordability and access to medication is one of the greatest ongoing areas of concern for pharma/biotech companies. While this is difficult in and of itself, companies must also navigate increased efforts from health plans to limit reimbursement of high cost therapeutics. Challenges continue to arise for manufacturers including formulary exclusions, high deductible plans, changes in benefit design, NDC blocks and step therapy programs.

CBI’s annual Formulary, Co-Pay and Access Summit tackles the hot button issues impacting the pharma/biotech industry today, including accumulator adjustment programs, state co-pay legislation, formulary exclusions, high deductible plans, changes in benefit design, NDC blocks and step therapy programs.

Featured Sessions Include:

  • Explore Perspectives on Accumulator Adjustment Programs and
    Identify Trends for the Future
  • Demystify California Copay Card Legislation and Assess
    Implications for Future State-Level Regulation
  • Views from the Trenches — Overcome Challenges of High Deductible
    Plans, Copay Caps and the Evolving Healthcare Landscape
  • Advanced Analytics — Turning Data into Actionable Knowledge
  • Maximize Speed to Therapy and Drive Brand Performance
    Throughout the Product Lifecycle
  • Navigate Value-Based Payment Models and the Evolving
    Managed Care Landscape to Maximize Copay Programs

Previous Attendee Acclaim:

CBI does a great job focusing on relevant and timely market and customer topics. Their staff is professional and accommodating. As a speaker as well as a leader that sends staff to these conferences, I am consistently satisfied and impressed with the discussions and takeaways.

VP, Contracting & Channel Marketing, Bayer

I’m always so thankful for the perspectives shared at CBI conferences. I always take away great industry knowledge
and a deeper understanding of the triumphs and
struggles of my industry partners.

Access Services Manager, Fairview Specialty Pharmacy

Excellent appraisal of approaches and philosophies in
market access and engagement.

Senior Director, Quality Strategic Consumer Group, Janssen

A cost-effective way to learn from thought leaders, peers and vendors in a topic area of interest. Especially useful at the beginning of the year to set performance goals and think
of new approaches to explore during the year.

Assistant Director, Payer Marketing, Acorda Therapeutics